122 Evaluating the feasibility and implementation of pharmacist-led pharmacogenomic testing in an ambulatory care setting
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103173
DOI: 10.1016/j.japh.2026.103173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von J. Oestreich und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Oestreich, J., Palisoc, E., Bennett, G., Guy, J., Hanavan, K., Bechtol, R., Ellerbrock, R., Griggs, R., Lifer-Surowiec, S., & Brim, T. (2026). 122 Evaluating the feasibility and implementation of pharmacist-led pharmacogenomic testing in an ambulatory care setting. Journal of the American Pharmacists Association, 66(4), 103173. https://doi.org/10.1016/j.japh.2026.103173
Vancouver
Oestreich J, Palisoc E, Bennett G, Guy J, Hanavan K, Bechtol R, et al. 122 Evaluating the feasibility and implementation of pharmacist-led pharmacogenomic testing in an ambulatory care setting. Journal of the American Pharmacists Association. 2026;66(4):103173. doi:10.1016/j.japh.2026.103173
BibTeX
@article{Oestreich2026,
author = {Oestreich, J. and Palisoc, E. and Bennett, G. and Guy, J. and Hanavan, K. and Bechtol, R. and Ellerbrock, R. and Griggs, R. and Lifer-Surowiec, S. and Brim, T.},
title = {122 Evaluating the feasibility and implementation of pharmacist-led pharmacogenomic testing in an ambulatory care setting},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103173},
doi = {10.1016/j.japh.2026.103173}
}
EUVIMED